By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3925 West Braker Lane

Austin  Texas  78759  U.S.A.
Phone: 512-961-1891 Fax: 512-305-0009



Company News
Mast Therapeutics (MSTX) Announces Possible Adjournment Of Special Stockholders Meeting To Solicit Additional Votes For Merger With Savara 4/20/2017 8:59:57 AM
Mast Therapeutics (MSTX) Reminds Stockholders To Vote For The Proposed Merger With Savara 4/17/2017 6:35:43 AM
Mast Therapeutics (MSTX) And Savara Announce Approval To List Common Stock On The Nasdaq Capital Market 4/10/2017 6:43:35 AM
Mast Therapeutics (MSTX) Sets Date For Special Meeting Of Stockholders To Vote On Proposed Merger With Savara 3/16/2017 10:53:35 AM
Mast Therapeutics (MSTX) And Savara Sign Merger Agreement 1/9/2017 7:06:35 AM
Savara Appoints David L. Lowrance As CFO 11/2/2016 9:05:54 AM
Savara Completes Acquisition Of Serendex Pharmaceuticals 7/18/2016 6:38:37 AM
Savara Acquires Serendex Pharmaceuticals 6/21/2016 6:56:51 AM
Savara Completes $20 Million Round Of Financing 3/1/2016 6:31:19 AM
Savara To Present At The 22nd Annual BioCentury Future Leaders In The Biotech Industry Conference 3/16/2015 10:13:47 AM